MAC/MAB–RCS: An Integrative Regulatory Control Framework for Risk Stratification and Personalized Intervention in Addiction Psychiatry
Open Access
- 3 February 2026
- journal article
- review article
- Published by MDPI AG in Brain Sciences
- Vol. 16 (2) , 187
Abstract
Objectives: Addiction disorders remain a major challenge in contemporary psychiatry due to high relapse rates and significant individual and societal burden. Despite advances in addiction neurobiology, current diagnostic frameworks and dominant models offer limited tools for early risk identification and dynamic support of clinical decision-making across the course of treatment. The aim of this narrative review is to introduce the MAC/MAB–RCS model as an integrated conceptual framework for risk stratification and personalized intervention in addiction psychiatry. Methods: The proposed model integrates evidence from four complementary domains: genetic, epigenetic, and stress-axis biomarkers; functional brain network organization; and psychological/psychiatric dimensions relevant to addictive behaviors. These domains are synthesized into a unified conceptual structure designed to capture dynamic regulatory processes underlying addiction vulnerability. Results: At the core of the model lies the Regulatory Control State (RCS), a latent higher-order construct representing an individual’s dynamic regulatory capacity through the integration of cognitive control, emotional regulation, and motivational drive modulation. Disruption of the RCS is conceptualized as a shared transdiagnostic mechanism driving craving escalation, compulsive behavior, and relapse vulnerability, independent of substance class or specific addictive behavior. Conclusions: The MAC/MAB–RCS model aligns with the principles of precision psychiatry by offering a pragmatic, clinically oriented translational framework with potential applicability across clinical settings, bridging neurobiological research and clinical practice. The review discusses its relationship to existing models, potential clinical and systemic applications, key limitations, and priorities for future validation studies.Keywords
All Related Versions
This publication has 38 references indexed in Scilit:
- Precision medicine in substance use disorders: Integrating behavioral, environmental, and biological insightsNeuroscience & Biobehavioral Reviews, 2025
- A transdiagnostic dimensional approach to behavioral dysregulation: Examining self-reported reward and punishment sensitivity across psychopathologyJournal of Affective Disorders, 2025
- Differences in fMRI-based connectivity during abstinence or interventions between heroin-dependent individuals and healthy controlsNeuroscience & Biobehavioral Reviews, 2025
- Emotional dysregulation in relation to substance use and behavioral addictions: Findings from five separate meta-analysesInternational Journal of Clinical and Health Psychology, 2024
- The Brain Salience Network at the Intersection of Pain and Substance use Disorders: Insights from Functional Neuroimaging ResearchCurrent Addiction Reports, 2024
- Psychological factors predicting patients' risk of relapse after enrollment in drug use treatment: A systematic reviewJournal of Substance Use and Addiction Treatment, 2024
- Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and preventionWorld Psychiatry, 2023
- Individual differences in computational psychiatry: A review of current challengesNeuroscience & Biobehavioral Reviews, 2023
- Theory-driven computational models of drug addiction in humans: Fruitful or futile?Addiction Neuroscience, 2023
- Addictions Neuroclinical Assessment: A Neuroscience-Based Framework for Addictive DisordersBiological Psychiatry, 2016